Gibson Wealth Advisors LLC purchased a new position in Cigna Group (NYSE:CI – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 873 shares of the health services provider’s stock, valued at approximately $289,000.
A number of other institutional investors have also recently modified their holdings of the stock. Financial Network Wealth Advisors LLC boosted its stake in Cigna Group by 26.8% in the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after purchasing an additional 34 shares in the last quarter. Central Pacific Bank Trust Division increased its stake in Cigna Group by 1.0% during the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after purchasing an additional 35 shares in the last quarter. NDVR Inc. raised its holdings in Cigna Group by 5.0% in the second quarter. NDVR Inc. now owns 779 shares of the health services provider’s stock worth $258,000 after buying an additional 37 shares during the last quarter. HBK Sorce Advisory LLC lifted its stake in shares of Cigna Group by 3.1% in the second quarter. HBK Sorce Advisory LLC now owns 1,263 shares of the health services provider’s stock worth $418,000 after buying an additional 38 shares in the last quarter. Finally, Legacy Financial Advisors Inc. grew its holdings in shares of Cigna Group by 2.9% during the first quarter. Legacy Financial Advisors Inc. now owns 1,400 shares of the health services provider’s stock valued at $461,000 after buying an additional 39 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
Cigna Group Price Performance
NYSE CI opened at $278.19 on Wednesday. The company has a 50-day moving average price of $285.92 and a 200-day moving average price of $297.87. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $74.31 billion, a P/E ratio of 15.18, a PEG ratio of 0.88 and a beta of 0.44.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 26.64%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the stock. TD Cowen decreased their price objective on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a report on Tuesday, November 4th. Morgan Stanley reissued an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft reduced their price objective on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Finally, Cantor Fitzgerald lowered their target price on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $334.05.
View Our Latest Research Report on CI
Insider Buying and Selling at Cigna Group
In related news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani bought 4,134 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.
Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than Cigna Group
- CD Calculator: Certificate of Deposit Calculator
- History Says These are 3 Stocks to Buy for December
- ETF Screener: Uses and Step-by-Step Guide
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- How to Profit From Value Investing
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
